Announcements Trials
Browse Landscape

Status

Completed 40Unknown 19Recruiting 7Terminated 4Not yet recruiting 4Active not recruiting 4Enrolling by invitation 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 129Observational 4

Sponsor

Cancer Type

Gastrointestinal 3Breast 1

Conditions

Unresectable Hepatocellular Carcinoma 1Elderly Metastatic Colorectal Cancer Patients 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 38Blood Specimen Collection 24Specimen Handling 14Radiotherapy 12Surgical Procedures, Operative 10Interviews as Topic 10Observation 9Magnetic Resonance Spectroscopy 9Drug Therapy 9Data Collection 8Immunotherapy 7Watchful Waiting 5Tomography, X-Ray Computed 5Radiosurgery 5Nivolumab 5Mastectomy, Segmental 5Biopsy 5ribociclib 4palbociclib 4Therapeutics 4Positron Emission Tomography Computed Tomography 4Mental Status and Dementia Tests 4Magnetic Resonance Imaging 4Ipilimumab 4Immune Checkpoint Inhibitors 4High-Throughput Nucleotide Sequencing 4Echocardiography 4Bevacizumab 4lorlatinib 3atezolizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Observational × Bevacizumab × Clear all
NCT06117891 2026-05-12

REFINE-IO

Bayer

Active not recruiting
300 enrolled
Gastrointestinal

Unresectable Hepatocellular Carcinoma

NCT04158258 2026-04-23

A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

Hoffmann-La Roche

Active not recruiting
2,907 enrolled
Breast

Breast Neoplasms

NCT03451370 2026-04-15

COBRA

Istituto Oncologico Veneto IRCCS

Active not recruiting
121 enrolled
Gastrointestinal

Elderly Metastatic Colorectal Cancer Patients

NCT02394834 2026-04-13

An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer

Takeda

Active not recruiting
757 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡